Could a home device replace hospital stays for High-Risk pregnancies?
NCT ID NCT06859177
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether pregnant women with complications like pre-eclampsia or fetal growth restriction can use a remote device at home to monitor their baby's heart rate. Sixty participants between 32 and 37 weeks of pregnancy will try the device daily. Researchers will check how often the measurements work and how satisfied patients and doctors are.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remote eCTG monitoring device (Nemo Remote®)
What this could lead to
If successful, this could allow some high-risk pregnant women to monitor their baby's heart rate from home instead of staying in the hospital.
What could go wrong
This is a small, early feasibility study with only 60 participants. The device may not work reliably for everyone, and it is not yet proven to improve health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY RELATED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maxima Medical Center
RECRUITINGVeldhoven, North Brabant, 5504DB, Netherlands
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••